Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
BRMS1 reduces the metastatic potential, but not the tumorogenicity, of human breast cancer and melanoma cell lines. Additionally we are shipping BRMS1 Antibodies (79) and BRMS1 Kits (7) and many more products for this protein.
Showing 7 out of 9 products:
The results showed that reduction in the breast cancer metastasis suppressor 1 [BRMS1] expression level was linked directly to clinico-pathological features of breast cancer significantly. The loss of expression or reduced levels of BRMS1 is potentially a strong indicator of the metastatic capacity of breast cancer with poor prognosis.
The RAS-related nuclear protein (show RAN Proteins) ((P) ran), breast cancer metastasis suppressor 1 ((P) brms1) and minichromosome maintenance complex component 5 (show MCM5 Proteins) ((P) mcm5 (show MCM5 Proteins)) promoters have the specificity and strength needed for cancer-specific expression-targeted gene therapy.
we identify a therapeutically exploitable posttranslational mechanism by which CK2alpha-mediated degradation of BRMS1 promotes metastases in lung cancer
our study characterized DAPK1 (show DAPK1 Proteins) as a novel transcriptional target of BRMS1. Transcriptional activation of DAPK1 (show DAPK1 Proteins) might be another important mechanism accounting for the metastasis suppressive activity of BRMS1.
BRMS1 promoter methylation and aberrant protein expression seem to be related to high-risk types of human papilloma virus-induced carcinogenesis in uterine cervix.
miR (show MLXIP Proteins)-346 promotes migration and invasion of nasopharyngeal carcinoma cells via targeting BRMS1.
expression of BRMS1 and/or HPA (show HPSE Proteins) might be closely related to the carcinogenesis, clinical biological behaviors, and prognosis of gallbladder adenocarcinoma
A novel link has been discussed between CDK2 (show CDK2 Proteins) expression and cell migration by characterizing the CDK2 (show CDK2 Proteins)-mediated phosphorylation of BRMS1.
Phosphorylation of BRMS1 by CDK2 (show CDK2 Proteins) regulates the migration of tumor cells.
Data show that Cullin3 exerts its function through promoting breast-cancer metastasis suppressor 1 (BRMS1) protein degradation, which was associated with epithelial-mesenchymal transition (EMT (show ITK Proteins)), migration and invasion.
The Brms1 suppressed pulmonary metastasis and promoted apoptosis of tumor cells located in the lungs but not in the mammary glands.
BRMS1 may participate in transcriptional regulation via interaction with the mSin3.HDAC (show HDAC3 Proteins) complex
results show for the first time that BRMS1 contains both nuclear import and export signals enabling its nucleo-cytoplasmic shuttling
This gene reduces the metastatic potential, but not the tumorogenicity, of human breast cancer and melanoma cell lines. The protein encoded by this gene localizes primarily to the nucleus and is a component of the mSin3a family of histone deacetylase complexes (HDAC). The protein contains two coiled-coil motifs and several imperfect leucine zipper motifs. Alternative splicing results in two transcript variants encoding different isoforms.
breast cancer metastasis-suppressor 1
, breast cancer metastasis suppressor 1
, breast cancer metastasis-suppressor 1 homolog
, breast cancer metastasis-suppressor 1-like protein